Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2015 Nov;8(11):e003644; discussion e003644.
doi: 10.1161/CIRCIMAGING.115.003644.

Relation of Left Ventricular Mass to Prognosis in Initially Asymptomatic Mild to Moderate Aortic Valve Stenosis

Eva Gerdts  1 , Anne B Rossebø  2 , Terje R Pedersen  2 , Giovanni Cioffi  2 , Mai Tone Lønnebakken  2 , Dana Cramariuc  2 , Barbara P Rogge  2 , Richard B Devereux  2
Affiliations
Randomized Controlled Trial

Relation of Left Ventricular Mass to Prognosis in Initially Asymptomatic Mild to Moderate Aortic Valve Stenosis

Eva Gerdts et al. Circ Cardiovasc Imaging. 2015 Nov.

Abstract

Background: The prognostic importance of left ventricular (LV) mass in nonsevere asymptomatic aortic stenosis has not been documented in a large prospective study.

Methods and results: Cox regression analysis was used to assess the impact of echocardiographic LV mass on rate of major cardiovascular events in 1656 patients (mean age, 67 years; 39.6% women) with mild-to-moderate asymptomatic aortic stenosis participating in the Simvastatin Ezetimibe in Aortic Stenosis (SEAS) study. Patients were followed during 4.3 years of randomized treatment with combined simvastatin 40 mg and ezetimibe 10 mg daily or placebo. At baseline, LV mass index was 45.9+14.9 g/m(2.7), and peak aortic jet velocity was 3.09+0.54 m/s. During follow-up, 558 major cardiovascular events occurred. In Cox regression analyses, 1 SD (15 g/m(2.7)) higher baseline LV mass index predicted increases in hazards of 12% for major cardiovascular events, 28% for ischemic cardiovascular events, 34% for cardiovascular mortality, and 23% for combined total mortality and hospitalization for heart failure (all P<0.01), independent of confounders. In time-varying models, taking the progressive increase in LV mass index during follow-up into account, 1 SD higher in-study LV mass index was consistently associated with 13% to 61% higher hazard for cardiovascular events (all P<0.01), independent of age, sex, body mass index, valvuloarterial impedance, LV ejection fraction and concentricity, and the presence of concomitant hypertension.

Conclusions: Higher LV mass index is independently associated with increased cardiovascular morbidity and mortality during progression of aortic stenosis.

Clinical trial registration: URL: http://www.clinicaltrials.gov. Unique identifier: NCT00092677.

Keywords: aortic valve stenosis; echocardiography; hypertrophy, left ventricular; mortality; prognosis.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Cumulative incidences of aortic valve events (AVE), ischemic cardiovascular (CV) events (ICE), CV death (CVD), and combined death from any cause and hospitalization for heart failure because of progression of aortic stenosis (DEATH&CHF) during >4.3 years of follow-up in relation to quartile of baseline left ventricular (LV) mass index in mild-to-moderate asymptomatic aortic stenosis.
Figure 2.
Figure 2.
Survival free from major cardiovascular (CV) events (A), aortic valve events (B), ischemic CV events (C), and combined death from any cause and hospitalization for heart failure because of progression of aortic stenosis (AS; D) in groups of patients with (—) and without (—-) left ventricular hypertrophy (LVH) on the baseline echocardiogram.
See this image and copyright information in PMC

Comment in

References

    1. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990;322:1561–1566. doi: 10.1056/NEJM199005313222203. - PubMed
    1. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med. 1991;114:345–352. - PubMed
    1. de Simone G, Izzo R, Chinali M, De Marco M, Casalnuovo G, Rozza F, Girfoglio D, Iovino GL, Trimarco B, De Luca N. Does information on systolic and diastolic function improve prediction of a cardiovascular event by left ventricular hypertrophy in arterial hypertension? Hypertension. 2010;56:99–104. doi: 10.1161/HYPERTENSIONAHA.110.150128. - PubMed
    1. Aurigemma GP, Silver KH, McLaughlin M, Mauser J, Gaasch WH. Impact of chamber geometry and gender on left ventricular systolic function in patients >60 years of age with aortic stenosis. Am J Cardiol. 1994;74:794–798. - PubMed
    1. Rieck AE, Cramariuc D, Staal EM, Rossebø AB, Wachtell K, Gerdts E. Impact of hypertension on left ventricular structure in patients with asymptomatic aortic valve stenosis (a SEAS substudy). J Hypertens. 2010;28:377–383. doi: 10.1097/HJH.0b013e328332fa44. - PubMed

Publication types

Associated data